Get Started

NAVBQ

PINK Navidea Biopharmaceuticals, Inc.
Nov 2, 2026 · 10:02 PM ET EOD Market Closed

$0.0000 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0000, and at the day’s high of $0.0000

YTD change
+0.00%
vs 20-day SMA
-99.43%
vs 200-day SMA
N/A

Price ranges

Previous day
$0.0000 $0.0000
open $0.0000 close $0.0000
+$0.0000 (+0.00%)
Today
$0.0000 $0.0000
open $0.0000 now $0.0000
+$0.0000 (+0.00%)
Past week
$0.0000 $0.0001
from $0.0000 now $0.0000
+$0.0000 (+0.00%)
Past month
$0.0000 $0.0010
from $0.0000 now $0.0000
+$0.0000 (+0.00%)
This year
$0.0000 $0.0010
from $0.0000 now $0.0000
+$0.0000 (+0.00%)

Price & Performance

-0.00 (+0.00%) / 6M

$-0.0001$0.0003$0.0007$0.0011May 4Jul 28Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 100.0% away from all-time highs of $0.0030
  • NAVBQ is up 0% since the beginning of the year
  • NAVBQ is up 0% over the past 12 months
  • NAVBQ is up 0% over the past 1 month

NAVBQ reads n/a: the 12-month move is -100.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Beta 53.61

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Market cap $100.1

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Columbus, OH.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.